DDF17

Pharma

Those pricing pledges? Maybe they weren't a good idea

Amid reports that AbbVie considered backing off its price-cap pledge for 2018, some wondered why companies would make such a pledge in the first place.

Carly Helfand Sep 27, 2017 12:35pm

Biotech vets weigh in on getting drugs through Gottlieb’s FDA

Sep 27, 2017 10:55am